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Abstract 
 
The phenomenon of poly-drug use is prevalent in Ireland.  Statistics from the National Drug Treatment 
Reporting System show that this behaviour is increasing, from 5590 cases treated in 1998 to 7845 cases 
treated in 2002.  The most frequent combinations include: heroin and cannabis when two drugs are 
implicated; heroin, methadone and benzodiazepines when three drugs are involved; and heroin, methadone, 
benzodiazepines and cannabis when four drugs are consumed.  Opiate-related deaths account for the 
largest proportion of fatalities amongst drug users, with most of the deaths attributable to consumption of 
heroin in combination with benzodiazepines, alcohol, methadone and cocaine.  There is a significant 
problem of driving under the influence of drugs in Ireland.  Results of a nationwide survey carried out by the 
Medical Bureau of Road Safety demonstrates that there is a strong trend of increasing positive drug tests 
with decreasing levels of alcohol, 68% of drivers with blood alcohol concentrations below the legal limit were 
positive for one or more drugs.  There is a need for treatment services dealing with poly-drug use as services 
in Ireland remain focussed on individual drugs of abuse. 
 
Introduction 
 
The World Health Organisation (WHO) defines poly-drug or multiple drug use as, 
“The use of more than one drug or type of drug by an individual, often at the same time or sequentially, and 
usually with the intention of enhancing, potentiating, or counteracting the effects of another drug.  The term is 
also used more loosely, to include the unconnected use of two or more drugs by the same person.  It carries 
the connotation of illicit use, although alcohol, nicotine, and caffeine are the substances most frequently 
taken simultaneously in developed societies.” 
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The phenomenon of poly-drug use in Ireland has been severely under-investigated, despite increased 
attention on drug misuse issues, and no report has been published which deals specifically with poly-drug 
consumption at a national level.   Compared to their exclusive drug or alcohol using counterparts, poly-drug 
users are more likely to consume greater quantities of drugs, exhibit more symptoms of psychopathology, 
and are more prone to act aggressively, to engage in acts of domestic violence or other criminal conduct.
2  
Poly-drug use in Ireland is not an emerging practice.  It was demonstrated in the earliest prevalence studies 
of opiate use in Ireland in the early 1980’s, and as illustrated in Table 1, continues to be a significant problem 
amongst individuals in drug treatment programmes. 
 
Table 1:  Studies of Poly-drug use in Ireland 
Author Sample Source Data Collection Definition of Poly-drug 
Use 
Evidence of Poly-drug Use 
Carr et al 
(1980)3 
Treatment centre 
(n=100) 
Interviews Use of ≥2 drugs in last 
month excluding opiates 
25% reported poly-drug use in the last month 
Bradshaw (1983)4 Opiate users in 
the community 
(n=82) 
Interviews 
 
Lifetime usage Almost 75% use heroin & other drugs 
Dean et al 
(1984)5 
Opiate users in 
the community 
(n=36) 
Interviews Drug usage in 12 months 
prior to interview 
92% using heroin, cannabis & others 
Lavelle (1985)6 Opiate users in 
the community 
(n=74) 
Interviews Lifetime usage 33% report daily use of heroin & methadone 
Keogh (1997)2 Garda records 
(n=352) 
Garda interviews Lifetime usage 96% report heroin use: 35% use methadone,33% use 
cannabis, 20% use ecstasy & 13% use cocaine in addition 
to heroin 
Cassin et al 
(1998)7 
Health Promotion 
Unit (n=770) 
Self report 
questionnaire 
Drug use in previous 
month 
67.4% < 25 years & 63.5% > 25 years reported poly-
drug use (individual drugs not specified) 
Centre for Health Irish prisons Self report Drug use in previous 3 63% of males & 83% of females used cannabis plus other 
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Promotion 
Studies (2000)8 
(n=777) questionnaire months  
 
Drug use in previous 12 
months 
drugs  
 
47% of males & 52% of females used amphetamines plus 
heroin 
 
 
Prevalence & Combinational Poly-drug Use 
 
Drug treatment data is observed as an indicator of drug misuse and of demand for treatment services.  The 
prevalence of poly-drug use in Ireland can be identified using The National Drug Treatment Reporting 
System (NDTRS), an epidemiological database monitoring treated problem drug use.  This data is used at 
national and European levels to provide information about the features of clients entering treatment and 
patterns of drug misuse; formulations of drugs used and consumption behaviours.  Information about the 
types of drugs consumed is central to developing individualised treatment plans for drug detoxification. 
           
Statistics from the NDTRS shows that poly-drug use in Ireland is increasing, 5590 cases were treated in 
1998 compared with 7845 cases in 2002.
9
  Between 1998 and 2002, 33,391 cases of drug misuse were 
treated in Ireland.  Of these, 28% reported problem use of one drug, 32% reported problem use of two drugs, 
26% reported problems with three drugs and 15% reported problems with four or more drugs.  Where an 
opiate was the main problem drug, the most common additional problem drug was cannabis, followed by 
benzodiazepines, other opiates and then cocaine; whereas when cannabis was the main drug of abuse, the 
most common additional drug were ecstasy, followed by alcohol and then amphetamines.
9
     
 
Where two drugs only were reported as being used on a daily basis (Table 2), heroin and cannabis, and 
heroin and benzodiazepines were the most common combinations, accounting for 45% of all two drug 
combinations.  A further 15% used a daily methadone and benzodiazepine combination.  
 
Table 2:  The combinations of drugs used by all treatment contacts reporting daily use of two drugs only in the month 
prior to treatment, reported to the NDTRS (1999)
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Drug Combination  
(2 drugs only) 
N (%) 
Heroin + Cannabis 
Heroin + BZN’s 
Methadone + BZN’s 
Heroin + Methadone 
Heroin + Cocaine 
Other Combinations 
174 (23.5) 
159 (21.5) 
108 (14.6) 
85 (11.5) 
34 (4.6) 
180 (24.3) 
Total 740 (100) 
BZN = Benzodiazepine 
 
Where three drugs only were reported as being used on a daily basis (Table 3), heroin, methadone and 
benzodiazepines was the most common combination, accounting for over 31% of reports.  A daily heroin, 
benzodiazepine and cannabis combination was used by a further 16.5 %. 
 
Table 3:  The combinations of drugs used by all treatment contacts reporting daily use of three drugs only in the month 
prior to treatment, reported to the NDTRS
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Drug Combination (3 drugs only) N(%) 
Heroin + Methadone + BZN’s 
Heroin + BZN’s + Cannabis 
Heroin+Methadone + Cannabis 
Methadone + BZN’s + Cocaine 
Methadone+ BZN’s + Cannabis 
Other Combinations 
59 (31.4) 
31 (16.5) 
13 (6.9) 
9 (4.8) 
6 (3.2) 
70 (37.2) 
Total 188 (100) 
BZN = Benzodiazepine 
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Where four drugs only were being taken on a daily basis the most common combination of drugs used was 
heroin, methadone, benzodiazepine and cannabis.  A total of 7 (25%) of the 28 treatment contacts using four 
drugs daily used this combination.
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Of the treated cases reporting problem use of more than one drug in addition to heroin, the order of 
additional drugs ranked from most to least common remained similar between 1998 and 2000, namely: 
benzodiazepines, cannabis, opiates, ecstasy, cocaine and alcohol.
9
  In 2001 and 2002, the status changed, 
with cannabis replacing benzodiazepines as the most common drug, while cocaine moved from fifth most 
common to third most common in 2002.
9
    
 
Concurrent opiate and benzodiazepine use is a common practice amongst drug-users (Table 5).  The 
combination of these two drugs may have implications for the efficacy of opiate treatment programmes.  If 
opiate dependence is treated in isolation, while co-existing benzodiazepine dependence is neglected, the 
potential exists for drug specific treatment programmes, such as methadone maintenance, to be 
undermined.  It is important that all aspects of poly-drug abuse are targeted to maximise benefit to the 
individual.   
 
Table 4:  The combination of heroin and benzodiazepines amongst drug using individuals in Ireland 
Author Sample Source Data Collection Definition of 
poly-drug use 
Combination 
Rooney et 
al (1998)10 
Treatment 
Centre 
(n=63) 
Interviews and urine 
analysis 
Lifetime usage 34% of sample tested positive for opiate and benzodiazepine 
use  
Browne et 
al (1998)11 
Treatment 
Centre 
(n=107) 
Urine/analysis Drug use in 
30 days prior 
to test 
45% tested positive for using benzodiazepines while using 
methadone  
Farrell 
(2000)12 
 
Treatment 
Centres 
(n=18142) 
Urine/analysis Drug use in 
30 days prior 
to test 
65% tested positive for benzodiazepine use while taking 
methadone  
 
 
Drug-related Fatalities 
 
Drug-related deaths and deaths among drug users are indicators of the consequences of problem drug use 
in Ireland.  Mortality trends facilitate monitoring of the impact of drug treatment programmes and drug 
prevention and harm reduction strategies.  The European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) identified drug-related deaths and deaths among drug users as one of the five key indicators of 
drug misuse in Europe.
13
  At present, it is difficult to ascertain the exact number of deaths among drug users 
in Ireland, the best estimate for Dublin ranges between 60 and 90 fatalities per annum.
14
  However, it has 
been suggested that these figures may underestimate the extent of the problem.
14
   
Opiate-related deaths account for the largest proportion of deaths among drug users in Ireland.  Results of 
toxicological analyses of fatal and non-fatal overdoses associated with illegal drug use are not widely 
available, but those that are, consistently reveal that the majority of deaths are associated with heroin use in 
combination with other drugs.
14
  The probable mode of death is respiratory depression.  Opiates depress the 
respiratory control centre, reducing its sensitivity to carbon dioxide and oxygen, resulting in hypoxia and 
subsequent cardiac arrest.  Benzodiazepines, alcohol, methadone and cocaine are the substances most 
frequently found in combination with opiates.
15
  These centrally-acting agents enhance the respiratory 
depressant effects of opiates, thereby increasing the likelihood of an adverse outcome.  
 
A review by Byrne of the files on drug and alcohol related deaths investigated by the Dublin City coroner in 
1998
16
 revealed that of the 520 inquests held in that year, drugs or alcohol were implicated in 108 of these.  
After exclusion of cases which were deemed to be primarily alcohol related (28), and suicides or possible 
suicides (10), a cohort of 70 remained that were believed to be exclusively drug related deaths. The majority 
of these deaths occurred in males aged less than 44 years.  A single drug was implicated in only 7 (10%) of 
these fatalities.  Twenty four cases (34.2%) were positive for two drugs, 25 (35.7%) for three drugs, 13 
(18.6%) for four drugs and 1 case (1.4%) was positive for 5 drugs.  Benzodiazepines were implicated in 69% 
of cases, methadone in 53%, heroin in 51% and alcohol in 43%.  Between 1
st
 January 1998 and the 31
st
 
December 2000, the Dublin City and County Coroners conducted 2063 inquests into deaths due to unnatural 
causes within their jurisdictions, 254 (12%) of which were related to the use of opiates.
16  
A single drug was 
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implicated in only 6.7% of drug related deaths.  Table 6 characterises the number of drugs implicated in 
death due to unnatural causes: 
 
Table 6:  Number of drugs implicated in deaths due to unnatural causes from 1998 to 2000, Byrne (2001)
16
 
Number of Drugs Frequency Percentage % 
0 5 2.0 
1 17 6.7 
2 53 20.9 
3 70 27.6 
4 60 23.6 
5 36 14.2 
6 9 3.5 
7 3 1.2 
10 1 0.4 
Total 254 100 
 
Benzodiazepines were implicated in the highest number of fatalities (71%), with diazepam the drug most 
cited (68%) in this regard.  Heroin was implicated in 62% of fatalities and methadone was involved in 57% of 
fatalities.  There were 6 ecstasy-related deaths during the three-year period.
16
 
 
Driving Under the Influence of Drugs 
 
The number of injuries and deaths due to road traffic accidents in Ireland is a cause for serious concern.  
The Government Strategy for Road Safety has identified four major factors as contributory causes in road 
traffic accidents: speeding, non-use of safety belts, careless and dangerous driving and intoxication.
17
  
Alcohol intoxication has long been recognised as a major contributor to road traffic collisions, and it remains 
the major intoxicant in drivers. The Road Traffic Act 1994 set the legal limits of alcohol at 80 mg/100ml in 
blood and 107mg/100ml in urine.  Increasingly, intoxication with drugs other than alcohol has been 
recognised, even though driving under the influence of drugs has been illegal under statute since the 1961 
Road Traffic Act.  The significant effect of drugs on motor performance is evident from the number of drivers 
apprehended for dangerous or careless driving, while under the alcohol limit or with no alcohol present at all.  
Results of a nationwide survey carried out between 2000 and 2001 on drivers who were detained for 
dangerous driving by the Medical Bureau of Road Safety demonstrates that there is a strong trend of 
increasing positive drug tests with decreasing levels of alcohol.  Sixty eight per cent of tested drivers with 
undetectable levels of alcohol were positive for one or more drugs. However, 23% of tested drivers had a 
combination of positive drug tests and alcohol levels above the legal limit.  The classes of drugs found were 
similar in those who were over the legal alcohol limit and those who were under, with cannabis being the 
most common drug found.
17
   
 
Figure 1:   Prevalence of Drug Taking by Blood Alcohol Level in Tested Drivers, reported by MBRS, 2003
17
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Clearly, there is a significant problem of driving under the influence of drugs in Ireland.   This is a troubling 
finding, as the combination of alcohol and other drugs could markedly impair driving performance, 
contributing significantly to the morbidity and mortality associated with road traffic accidents.  
The combined effects of alcohol and drugs on individuals 
 
Concurrent poly-drug use is a style of ingestion where multiple drugs are consumed on separate occasions.  
The use of multiple drugs simultaneously may have a greater influence on individuals than concurrent poly-
drug consumption, by producing greater intoxication and increasing the risk of damage to health.  
Simultaneous poly-drug use increases psychological distress, as measured by depression, anxiety and 
phobic anxiety scales, compared with concurrent use.
18
   In addition, unique pharmacokinetic interactions 
may occur, resulting in the formation of metabolites of greater toxicity than those present when drugs are 
used individually.
19
   
 
The most common drug taken in combination with illegal drugs is alcohol.  The risks of a fatal overdose or 
toxic effects on major organs, such as the heart and liver, are greatly increased when drugs and alcohol are 
mixed.  The use of alcohol in combination with benzodiazepines has been shown to produce greater 
psychomotor impairment than that produced by each substance separately.
20
  Doses of benzodiazepines 
that are excessively sedating may cause severe drowsiness in the presence of alcohol, increasing the risk of 
household and automotive accidents.
21
  This may be especially significant in older people, who demonstrate 
an increased pharmacodynamic susceptibility to these drugs.  Similar super-additive effects have been found 
for alcohol and marijuana with regard to driving performance.
22
  Use of alcohol and marijuana in combination 
has also been shown to produce foetal damage at levels of alcohol consumption not normally associated 
with foetotoxicity.
23
   
 
The simultaneous use of alcohol and cocaine is popular amongst drug users.  A number of theories have 
been proposed to account for this: a more intense feeling of a ‘high’ beyond that perceived with either drug 
alone, to minimise alcohol-induced inebriation, and to assuage sensations associated with coming down 
from cocaine intoxication.  Cocaine and alcohol metabolites combine to form cocaethylene, an active 
metabolite which is more toxic than either drug alone. Cocaethylene is
 
the ethyl ester of benzoylecgonine, 
and is only formed following simultaneous ingestion of alcohol and cocaine.  It has been associated with 
enhanced subjective euphoria, increased heart rate
 
and increased plasma cocaine concentration.
24
  
Cocaethylene affects normal cardiac function and has been a contributory factor in many cocaine related 
deaths.
25
  It can also potentiate the tendency towards violent thoughts and threats, which may lead to an 
increase in violent behaviour.
26
 
 
Combined heroin and cocaine use has also been reported.
9
  It has been suggested that heroin enhances the 
rewarding effects of cocaine by reducing the anxiolytic side effects that occur after the positive euphoric 
reaction of cocaine diminishes.
27
  Both cocaine and µ opioid agonists activate reward pathways, the former 
by blocking dopamine uptake, the latter by enhancing mesolimbic dopamine release.  Furthermore, there is 
evidence to suggest that morphine and opiates may enhance the toxic potential of cocaine, and that cocaine 
can induce respiratory depression, possibly contributing to the ultimate mechanism of death in narcotic 
overdose cases.
28
 
 
Conclusions and Recommendations 
 
Poly-drug use is a common practice amongst drug users, and is associated with considerable morbidity and 
mortality.  More evidence-based research is needed to ascertain the best possible care for poly-drug users 
and especially for problem drug users.  In recent years, much emphasis has been placed on expanding 
treatment services, and this has to a large extent been achieved.  The challenge now is to widen the 
spectrum of treatment services, and refine the interventions themselves, thereby increasing their success 
rates.  Treatment for users of several drugs in the recreational scene is virtually non-existent, as most drug 
services are only equipped to deal with opiate and severe dependence problems and not stimulant poly-drug 
use.  Targeted initiatives to tackle the social origins of poly-drug problems should be addressed with inter-
agency co-operation and community participation.  Furthermore, there is a need to include legal drugs as 
part of the poly-drug treatment policy, since experience has shown that an exclusive focus on illegal drugs 
has limited effectiveness.  Policy makers must have a clear vision of what they wish to achieve within the 
context of poly-drug use in Ireland if they hope to combat this escalating crisis. 
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